{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:55:21Z","timestamp":1788479721327,"version":"build-2803163510"},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1392,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1365-2265.2011.04136.x","type":"journal-article","created":{"date-parts":[[2011,6,6]],"date-time":"2011-06-06T10:26:40Z","timestamp":1307356000000},"page":"819-824","source":"Crossref","is-referenced-by-count":52,"title":["Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma"],"prefix":"10.1111","volume":"75","author":[{"given":"Thomas M.","family":"Barber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kenkre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Garnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca V.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James V.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A. H.","family":"Wass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,11,9]]},"reference":[{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.beem.2009.05.003","article-title":"Pituitary tumours: the prolactinoma","volume":"23","author":"Colao","year":"2009","journal-title":"Best Practice and Research Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB2|cit2","first-page":"1085","article-title":"Clinical presentation of hyperprolactinemia","volume":"44","author":"Luciano","year":"1999","journal-title":"The Journal of Reproductive Medicine"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1210\/jc.85.9.3053","article-title":"Primary medical therapy of micro- and macroprolactinomas in men","volume":"85","author":"Pinzone","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejim.2008.11.012","article-title":"Long-term outcome of patients with macroprolactinomas initially treated with dopamine agonists","volume":"20","author":"Kars","year":"2009","journal-title":"European Journal of Internal Medicine"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00024677-200302010-00003","article-title":"Hyperprolactinemia: pathophysiology and management","volume":"2","author":"Verhelst","year":"2003","journal-title":"Treatments in Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/14656566.1.3.555","article-title":"Cabergoline","volume":"1","author":"Colao","year":"2000","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/jc.84.7.2518","article-title":"Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients","volume":"84","author":"Verhelst","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1586\/14737140.6.9s.S29","article-title":"Prolactin-secreting tumors: what\u2019s new?","volume":"6","author":"Molitch","year":"2006","journal-title":"Expert Review of Anticancer Therapy"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1530\/eje.0.1400043","article-title":"Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists?","volume":"140","author":"Turner","year":"1999","journal-title":"European Journal of Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","article-title":"Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas","volume":"65","author":"Casanueva","year":"2006","journal-title":"Clinical Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1210\/jc.2008-2103","article-title":"Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy","volume":"94","author":"Kharlip","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1056\/NEJMoa022657","article-title":"Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia","volume":"349","author":"Colao","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2265.2007.02905.x","article-title":"Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy","volume":"67","author":"Colao","year":"2007","journal-title":"Clinical Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/jc.2009-1238","article-title":"Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis","volume":"95","author":"Dekkers","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB16|cit16","first-page":"130","article-title":"MRI: incidence and evaluation of size and form criteria in hypophysis-healthy probands and in patients with detectable microadenomas","volume":"7","author":"Dietrich","year":"1997","journal-title":"Aktuelle Radiologie"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB17|cit17","first-page":"47","article-title":"MRI - diagnostic and follow-up tool for microprolactinomas","volume":"15","author":"Seidl","year":"2000","journal-title":"Functional Neurology"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF03343573","article-title":"Cabergoline: a first-choice treatment in patients with previously untreated prolactin-secreting pituitary adenoma","volume":"22","author":"Cannavo","year":"1999","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2265.2005.02293.x","article-title":"Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas","volume":"63","author":"Biswas","year":"2005","journal-title":"Clinical Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04136.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1210\/jc.87.8.3578","article-title":"Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawal","volume":"87","author":"Passos","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2011.04136.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2265.2011.04136.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T18:43:29Z","timestamp":1625424209000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2011.04136.x"}},"subtitle":["<i>Hyperprolactinaemia recurrence in prolactinoma<\/i>"],"short-title":[],"issued":{"date-parts":[[2011,11,9]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04136.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13477052.14858059","asserted-by":"object"}]},"ISSN":["0300-0664"],"issn-type":[{"value":"0300-0664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11,9]]}}}